TGFB1 and familial pancreatic carcinoma: Among alterations occurring in pancreatic cancer, TGF-β signalling pathway is frequently lost as SMAD4/DPC4 (deleted in pancreatic cancer 4) is mutated in 50–80% of PDAC and mutations of TGF-βRII are also described (5–10%) [3,5].